Jubilant Biosys Ltd., a Bangalore-based subsidiary of Jubilant Organosys, has signed a research collaboration agreement with AstraZeneca focused on delivering preclinical drug candidates into AZ’s pipeline. The shared risk-reward collaboration will initially focus on neuroscience. AZ will own the compounds developed under the collaboration with worldwide development and commercialization rights. Jubilant will be eligible to receive research funding for an initial five-year period. AZ wi...